Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area metabolism pde'

Search results for: 'research area metabolism pde'

Items 91-100 of 130

Page
per page
  1. Milrinone
    B1386 Milrinone
    Target: Phosphodiesterases (PDEs)
    Summary: PDE-3 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥8.2 mg/mL
  2. NSI-189
    B1150 NSI-189
    Summary: Nootropic and neurogenic research chemical
      Soluble in DMSO
  3. (±)-Decanoylcarnitine chloride
    B6315 (±)-Decanoylcarnitine chloride
    Summary: intermediate in lipid metabolism
      <35.19 mg/mL
  4. (±)-Acetylcarnitine chloride
    B6273 (±)-Acetylcarnitine chloride
    Summary: weak cholinergic agonist; intermediates in lipid metabolism
      <23.97 mg/mL
  5. (±)-Myristoylcarnitine chloride
    B6354 (±)-Myristoylcarnitine chloride
    Summary: cholinergic agonist; important intermediates in lipid metabolism
      <10.2 mg/mL
  6. HNGF6A
    B7764 HNGF6A
    Summary: increases glucose stimulated insulin secretion and glucose metabolism
      Soluble to 1 mg/mL
  7. Malotilate
    A2486 Malotilate
    Summary: Stimulates hepatocyte regeneration
      insoluble in H2O; ≥14.419 mg/mL
  8. Orotic acid
    B1147 Orotic acid
    Summary: Pyrimidinecarboxylic acid
      insoluble in H2O; insoluble in EtOH; ≥15.6 mg/mL
  9. Gemcitabine
    A8437 Gemcitabine
     1 Citation
    Summary: inhibitor of DNA synthesis
      ≥11.75 mg/mL
  10. Oxyntomodulin
    B5259 Oxyntomodulin
    Summary: Endogenous glucagon-like peptide that modulates feeding and metabolism
      Soluble to 1 mg/mL

Items 91-100 of 130

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
Clear All
Shopping Options
Category
  1. Proteases 1 item
  2. Apoptosis 1 item
  3. Metabolism 100item
  4. Tyrosine Kinase 1 item
  5. DNA Damage/DNA Repair 2item
  6. PI3K/Akt/mTOR Signaling 2item
  7. Microbiology & Virology 2item
  8. GPCR/G protein 3item
  9. Stem Cell 1 item
  10. Membrane Transporter/Ion Channel 3item
  11. Cancer Biology 1 item
  12. Endocrinology and Hormones 1 item
  13. Neuroscience 3item
  14. Others 9item
  15. Immunology/Inflammation 4item
  16. Vitamin D Related 1 item
Specificity
  1. Selective 46item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 1 item
  2. Irreversible 4item
Target
  1. Acyl coenzyme A: cholesterol acyltransferases 1 item
  2. Factor Xa 1 item
  3. Phosphodiesterases (PDEs) 13item
  4. RARs 1 item
  5. Estrogen and Related Receptors 1 item
  6. Stearoyl-CoA 9-desaturase (SCD-1) 1 item
  7. AMPK 1 item
  8. Cytochrome P450 (CYP450) 4item
  9. Ferroptosis 1 item
  10. HMG-CoA Reductases 3item
  11. SGLT 1 item
  12. DGAT 2item
  13. Insulin and Insulin-like Receptors 1 item
  14. Pyruvate dehydrogenases (PDH) 1 item
  15. CETP 2item
  16. Fatty-acid-binding proteins (FABPs) 1 item
  17. Folate Analogue 1 item
  18. IDH2 1 item
  19. Nampt 1 item
  20. Carbonic Anhydrases 3item
  21. Histamine H1 Receptors 1 item
  22. Phospholipases 1 item
  23. Catechol O-Methyltransferase (COMT) 1 item
  24. Hydroxylases 1 item
  25. ATGL 1 item
  26. FPTase 1 item
  27. PPAR 1 item
  28. FAAH 1 item
  29. carnitine reabsorption 1 item
  30. TRPC channel 1 item
Reported Experiments
  1. Animal Experiments 61item
  2. Cell Experiments 51item
Related Disease
  1. Acne 1 item
  2. Acute Kidney Injury 1 item
  3. Acute Myelogenous Leukemia 1 item
  4. Bladder Cancer 1 item
  5. Bladder Carcinoma 1 item
  6. Brain Injuries Studies 1 item
  7. Breast Cancer 5item
  8. Cancer 14item
  9. Cervical Cancer 1 item
  10. Cocaine-Related Disorders 1 item
  11. Diabetes 1 item
  12. Dyslipidemia 2item
  13. Erectile Dysfunction 3item
  14. HIV 1 item
  15. Hypercholesterolemia 2item
  16. Inflammation 1 item
  17. Inflammatory Diseases 2item
  18. Kidney Injury Studies 1 item
  19. Leukemia 2item
  20. Lung Cancer 2item
  21. Lymphoma 3item
  22. Melanoma 2item
  23. Neuroblastoma 3item
  24. Neurocognitive Disorders 1 item
  25. Obsessive-Compulsive Disorder 1 item
  26. Prostate Cancer 2item
  27. Psoriasis 2item
  28. Psoriasis Vulgaris 1 item
  29. Pulmonary Arterial Hypertension 1 item
  30. Rheumatoid Arthritis 2item
  31. Schizophrenia 2item
  32. Type 2 Diabetes 4item